Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-058607

Chief Financial Officer acquired 54,604 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kalowski Lee Chief Financial Officer 2014-09-17 Grant or award +54,604 54,604 D
Derivatives
Kalowski Lee Chief Financial Officer 2014-09-17 Grant or award · Stock Option (right to buy) +218,417 218,417 D
Loading xslF345X03/doc4.xml…